| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 117,688 | 123,739 | 153,138 | 230,546 | | Cost of Revenue | 92,756 | 96,743 | 118,955 | 160,609 | | | Gross Profit | 24,932 | 26,996 | 34,183 | 69,937 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,751 | 18,593 | 18,430 | 21,250 | | Non Recurring |
-
| 2,000 | 3,000 | 6,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,181 | 6,403 | 12,753 | 42,687 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 622 | 849 | 667 | (670) | | Earnings Before Interest And Taxes | 7,803 | 7,252 | 13,420 | 42,017 | | Interest Expense | 151 | 174 | 127 | 10 | | Income Before Tax | 7,652 | 7,078 | 13,293 | 42,007 | | Income Tax Expense | 2,597 | 2,327 | 4,210 | 15,706 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,055 | 4,751 | 9,083 | 26,301 | | | Non-recurring Events | | Discontinued Operations | (63) | (254) | (105) | 265 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,992 | 4,497 | 8,978 | 26,566 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,992 | $4,497 | $8,978 | $26,566 |
|
0.51% Nasdaq 
Income Statement
